1422 related articles for article (PubMed ID: 21710108)
1. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
2. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
8. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
10. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
Su P; Aw CW
Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
[TBL] [Abstract][Full Text] [Related]
11. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
12. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
[TBL] [Abstract][Full Text] [Related]
15. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
Teo L; Tay YK; Liu TT; Kwok C
Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
[TBL] [Abstract][Full Text] [Related]
17. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
Sharma VK; Sethuraman G; Minz A
Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
[TBL] [Abstract][Full Text] [Related]
18. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
19. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]